Cancer Research & Treatment Fund, Inc.

Home
Cancer Research & Treatment Fund, Inc.

The official page of Cancer Research & Treatment Fund. Please follow us to receive our latest news. In 2012, CR&T began funding the Richard T. Silver.

ablishment of the Center for the Study of Leukemia and Myeloproliferative Neoplasms at Weill Cornell Medical College, a leading institution for cancer research. More recently, we have been involved with the breakthrough discoveries of Gleevec and now the JAK2 enzyme cancer marker . Silver Myeloproliferative Neoplasm Center at Weil Cornell Medical College, the successor to the Center for the Study of Leukemia and Myelproliferative Neoplasms at Weill Cornel Medical College. The center was dedicated in a special ceremony on February 18, 2014, and will serve as a translational research and treatment center, engaging in cutting edge discoveries surrounding MPNs. CR&T played a pivotal role in establishing the Silver MPN Center. In addition to contributing a $3.7 million gift, the Center is named after CR&T’s founder, Dr. Richard T. Dr. Andrew Schaefer, former Chairman of the Department of Medicine at Weill Cornell Medical College, has been appointed as the Center’s Director. We have achieved these successes by aggressively pursuing biological, pharmacological and molecular solutions to understand cancer, and to design drugs and diagnostic tools based on new knowledge—providing critical resources for a multidisciplinary approach that offers the greatest promise against all forms of cancer. For more than three decades, CR&T has been a major source of financial support for researchers on the frontlines of clinical cancer research at Weill Medical College of Cornell University, located at New York-Presbyterian Hospital. We have also awarded grants for research at Johns Hopkins University Medical Center, MD Anderson Cancer Center and Memorial Sloan-Kettering Cancer Center.

23/07/2025

CR&T recently approved the 2nd year of funding of a 2 year grant to Despina Siolas, MD, PhD. Her work is truly impactful and we are proud to support her research!

💙

16/07/2025

Living with an MPN? Here are daily wellness tips that can help:

🌿 Stay active (gentle walks count!)
🥗 Eat whole, anti-inflammatory foods
🧘 Manage stress with mindfulness
👩 ⚕ Keep regular check-ins with your care team

24/06/2025

Behind every patient is someone who listens, supports, and loves. 💛

Let's celebrate caregivers — the unsung heroes of every MPN journey.

Tag a caregiver you admire.

13/06/2025

MPN Fact Friday

Fact: Most MPNs are chronic conditions, but advances in research are helping patients live longer, fuller lives.

Share to raise awareness!

11/06/2025

Your donation = Hope.

💰 Every dollar funds life-saving research into treatments for MPNs and other blood cancers.
This month, help us move one step closer to a cure.

👉 Donate today: https://www.crt.org/donate/

02/06/2025

📢 This month, CR&T is raising awareness for blood cancers, including Myeloproliferative Neoplasms (MPNs). MPNs are rare blood cancers that can impact anyone — but together, we can make a difference.

🩸 Learn. Share. Support.

14/05/2025

At CR&T, we’re committed to funding research that leads to better treatments and, ultimately, cures for blood cancers. Your donation helps fund life-saving research into myeloproliferative neoplasms (MPNs) and other cancers, giving patients and families the hope they deserve.

Be a part of the solution. Every donation, no matter the size, brings us one step closer to a world without blood cancer. 💪

🔹 Donate now: https://www.crt.org/donate/

&T

01/05/2025

this Saturday at First Presbyterian Church in Jamaica.

21/04/2025

We stand together to raise awareness for Acute Myeloid Leukemia—a fast-moving, life-threatening blood cancer. Early detection, research, and support are key to improving outcomes.

Let’s honor the fighters, remember the loved ones we’ve lost, and support the search for a cure.

Wear orange. Share the message. Help make a difference.

18/04/2025

To all the caregivers supporting loved ones diagnosed with myeloproliferative neoplasms (MPNs), we see you and we thank you. Your dedication, compassion, and strength provide an unwavering source of comfort and hope.

Whether you’re accompanying them to doctor’s appointments, offering emotional support, or managing daily care, your role is essential in the journey toward healing. Your love makes all the
difference.

We celebrate you today and every day! 🙏

12/04/2025

With over $17 million awarded to research, CR&T has been funding critical advancements in blood cancer treatment for over 55 years. But we need your help to keep going!

By donating to CR&T, you’re not just giving money—you’re giving hope. Your contribution fuels the research that could one day lead to a cure for blood cancers like myeloproliferative neoplasms
(MPNs).

Together, we can make a lasting impact. 🙏

💖 Donate today: https://www.crt.org/donate/

&T

08/04/2025

When facing cancer, it’s easy to focus solely on the physical aspects of treatment, but mental health is just as crucial. A cancer diagnosis can bring fear, uncertainty, and emotional challenges, which is why it’s important to prioritize your emotional well-being.

Whether through meditation, therapy, or simply talking to others who understand, caring for your mental health can improve resilience, aid recovery, and bring peace during a difficult time.

You don’t have to face this alone—reach out for support when you need it.

&T

Address

Opening Hours

Monday	09:30 - 17:30
Tuesday	09:30 - 17:30
Wednesday	09:30 - 17:30
Thursday	09:30 - 17:30
Friday	09:30 - 17:30

Website

http://www.crt.org/

Alerts

Be the first to know and let us send you an email when Cancer Research & Treatment Fund, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cancer Research & Treatment Fund, Inc.:

Shortcuts

Address
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing
Want your practice to be the top-listed Clinic?

Country:

City:

Our Story

The Cancer Research and Treatment Fund (CR&T) is a driving force in cancer research and treatment. Founded in 1968, we are a not-for-profit fund that is committed to the belief that advances in blood cancer research lead to important breakthroughs, and a better understanding of the biology and treatment of all forms of cancer. In 2000, CR&T and the generosity of donors were instrumental in the establishment of the Center for the Study of Leukemia and Myeloproliferative Neoplasms at Weill Cornell Medical College, a leading institution for cancer research. More recently, we have been involved with the breakthrough discoveries of Gleevec and now the JAK2 enzyme cancer marker . In 2012, CR&T began funding the Richard T. Silver Myeloproliferative Neoplasm Center at Weil Cornell Medical College, the successor to the Center for the Study of Leukemia and Myelproliferative Neoplasms at Weill Cornell Medical College. The center was dedicated in a special ceremony on February 18, 2014, and serves as a translational research and treatment center, engaging in cutting edge discoveries surrounding MPNs. CR&T played a pivotal role in establishing the Silver MPN Center. In addition to contributing a $3.7 million gift, the Center is named after CR&T’s founder, Dr. Richard T. Silver. Dr. Andrew Schafer, former Chairman of the Department of Medicine at Weill Cornell Medical College, has been appointed as the Center’s Director. We have achieved these successes by aggressively pursuing biological, pharmacological and molecular solutions to understand cancer, and to design drugs and diagnostic tools based on new knowledge—providing critical resources for a multidisciplinary approach that offers the greatest promise against all forms of cancer. CR&T will mark its 50th Anniversary in 2018. For nearly 50 years, the organization has been a major source of financial support for researchers on the frontlines of clinical cancer research at Weill Medical College of Cornell University, located at New York-Presbyterian Hospital. We have also awarded grants for research at Johns Hopkins University Medical Center, MD Anderson Cancer Center, and Memorial Sloan-Kettering Cancer Center.